Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03988 | 33800585 | Int J Environ Res Public Health | Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity. | 2021 | Details |
| A03998 | 33794916 | Nutr J | Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. | 2021 | Details |
| A04001 | 33794740 | Adipocyte | Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet. | 2021 | Details |
| A04005 | 33792864 | J Endocrinol Invest | Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets. | 2021 | Details |
| A04006 | 33791907 | Mol Biol Rep | Bioactive dipeptide from potato protein hydrolysate combined with swimming exercise prevents high fat diet induced hepatocyte apoptosis by activating PI3K/Akt in SAMP8 mouse. | 2021 | Details |
| A04011 | 33789906 | Sci Adv | Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders. | 2021 | Details |
| A04012 | 33789150 | J Nutr Biochem | The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. | 2021 | Details |
| A04018 | 33788095 | Dig Dis Sci | Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes. | 2021 | Details |
| A04019 | 33787507 | Dis Model Mech | Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver. | 2021 | Details |
| A04020 | 33787249 | J Agric Food Chem | Malvidin-3-O-Glucoside from Blueberry Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Transcription Factor EB-Mediated Lysosomal Function and Activating the Nrf2/ARE Signaling Pathway. | 2021 | Details |
| A04023 | 33785637 | Pediatrics | Alternative Etiologies of Liver Disease in Children With Suspected NAFLD. | 2021 | Details |
| A04028 | 33785007 | BMC Complement Med Ther | Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. | 2021 | Details |
| A04031 | 33783745 | Adv Exp Med Biol | Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH). | 2021 | Details |
| A04033 | 33782808 | Dig Dis Sci | Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank. | 2021 | Details |
| A04034 | 33782517 | Sci Rep | Non-alcoholic fatty liver disease in polycystic ovary syndrome women. | 2021 | Details |
| A04035 | 33780962 | Obes Facts | Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2021 | Details |
| A04037 | 33780425 | MEDICC Rev | Non-Alcoholic Fatty Liver Disease in Cuba. | 2021 | Details |
| A04039 | 33780129 | Am J Transplant | Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications. | 2021 | Details |
| A04040 | 33779880 | Dig Dis Sci | Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes. | 2021 | Details |
| A04044 | 33777700 | Toxicol Rep | Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis. | 2021 | Details |
| A04048 | 33776901 | Front Endocrinol (Lausanne) | Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice. | 2021 | Details |
| A04058 | 33773656 | Food Res Int | Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. | 2021 | Details |
| A04064 | 33772116 | Commun Biol | INPP4B protects from metabolic syndrome and associated disorders. | 2021 | Details |
| A04068 | 33771699 | Pharmacol Res | Epigenetics in NAFLD/NASH: Targets and therapy. | 2021 | Details |
| A04073 | 33769609 | FASEB J | CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis. | 2021 | Details |
| A04076 | 33768700 | J Dtsch Dermatol Ges | Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network? | 2021 | Details |
| A04087 | 33765728 | Clin Endosc | Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection. | 2021 | Details |
| A04093 | 33762736 | Nature | Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. | 2021 | Details |
| A04112 | 33753007 | Surg Obes Relat Dis | Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats. | 2021 | Details |
| A04115 | 33751907 | J Med Food | A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. | 2021 | Details |
| A04117 | 33751456 | Curr Obes Rep | Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives. | 2021 | Details |
| A04119 | 33750841 | Sci Rep | COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. | 2021 | Details |
| A04124 | 33748727 | JHEP Rep | Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation. | 2021 | Details |
| A04125 | 33748726 | JHEP Rep | NAFLD and MAFLD as emerging causes of HCC: A populational study. | 2021 | Details |
| A04126 | 33746906 | Front Endocrinol (Lausanne) | Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. | 2021 | Details |
| A04133 | 33746083 | J Hepatol | Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. | 2021 | Details |
| A04135 | 33745998 | J Pediatr | Under-reporting of Hepatic Steatosis in Children: A Missed Opportunity for Early Detection. | 2021 | Details |
| A04136 | 33745573 | Clin Nutr ESPEN | A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older. | 2021 | Details |
| A04138 | 33744305 | Gastroenterology | Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. | 2021 | Details |
| A04140 | 33743586 | BMC Gastroenterol | Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. | 2021 | Details |
| A04141 | 33743554 | Hepatology | Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04142 | 33743323 | Nutr Res | Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis. | 2020 | Details |
| A04149 | 33740939 | BMC Endocr Disord | Hemoglobin concentration is associated with the incidence of metabolic syndrome. | 2021 | Details |
| A04152 | 33739984 | PLoS One | Association between sarcopenia level and metabolic syndrome. | 2021 | Details |
| A04157 | 33736456 | Antioxid Redox Signal | Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk. | 2021 | Details |
| A04161 | 33733078 | JHEP Rep | European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease? | 2021 | Details |
| A04163 | 33732030 | Clin Pharmacol | Clinical Impact of Liraglutide as a Treatment of Obesity. | 2021 | Details |
| A04176 | 33727658 | Commun Biol | Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes. | 2021 | Details |
| A04177 | 33727164 | Clin Gastroenterol Hepatol | Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A04185 | 33723650 | Acta Diabetol | The long-term metabolic and neurocognitive risks in offspring of women with type 1 diabetes mellitus. | 2021 | Details |
| A04189 | 33722690 | Mol Metab | Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. | 2021 | Details |
| A04196 | 33720280 | Biochem J | α-Methyl-l-tryptophan as a weight-loss agent in multiple models of obesity in mice. | 2021 | Details |
| A04197 | 33720087 | J Pediatr Gastroenterol Nutr | Pediatric Non-Alcoholic Fatty Liver Disease Is Affected by Genetic Variants Involved in Lifespan/Healthspan. | 2021 | Details |
| A04200 | 33718398 | Front Med (Lausanne) | Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. | 2021 | Details |
| A04203 | 33716447 | World J Gastroenterol | G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. | 2021 | Details |
| A04205 | 33715205 | Clin Endocrinol (Oxf) | Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans. | 2021 | Details |
| A04206 | 33714861 | Complement Ther Clin Pract | Effect of green coffee bean extract supplementation on liver function and inflammatory biomarkers: A meta-analysis of randomized clinical trials. | 2021 | Details |
| A04209 | 33712680 | Sci Rep | Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. | 2021 | Details |
| A04211 | 33711964 | BMC Pediatr | Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. | 2021 | Details |
| A04214 | 33711421 | J Nutr Biochem | Dietary cocoa ameliorates non-alcoholic fatty liver disease and increases markers of antioxidant response and mitochondrial biogenesis in high fat-fed mice. | 2021 | Details |
| A04221 | 33709477 | J Gastroenterol Hepatol | Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A04227 | 33707081 | Best Pract Res Clin Endocrinol Metab | Gut microbiome and bile acids in obesity-related diseases. | 2021 | Details |
| A04228 | 33706959 | Vitam Horm | Ghrelin and adipokines: An overview of their physiological role, antimicrobial activity and impact on cardiovascular conditions. | 2021 | Details |
| A04229 | 33706839 | Epidemiol Psychiatr Sci | Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity. | 2021 | Details |
| A04234 | 33703947 | J Appl Physiol (1985) | High fat high sucrose diet-induced dyslipidemia in guinea pigs. | 2021 | Details |
| A04254 | 33688229 | Diabetes Metab Syndr Obes | Risk Factors Screening for Gestational Diabetes Mellitus Heterogeneity in Chinese Pregnant Women: A Case-Control Study. | 2021 | Details |
| A04257 | 33686111 | Sci Rep | A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery. | 2021 | Details |
| A04258 | 33685968 | Gut | Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. | 2021 | Details |
| A04259 | 33685807 | Dig Liver Dis | Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. | 2021 | Details |
| A04267 | 33684566 | Biochim Biophys Acta Mol Cell Biol Lipids | GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling. | 2021 | Details |
| A04268 | 33683797 | Int J Clin Pract | The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study. | 2021 | Details |
| A04269 | 33681678 | Hepatol Commun | High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease. | 2020 | Details |
| A04273 | 33680428 | Hepat Oncol | Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma. | 2020 | Details |
| A04274 | 33680375 | Caspian J Intern Med | Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges. | 2020 | Details |
| A04277 | 33679803 | Front Immunol | Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04279 | 33679386 | Front Pharmacol | Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice. | 2021 | Details |
| A04280 | 33679051 | J Clin Exp Hepatol | Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience. | 2020 | Details |
| A04285 | 33678036 | Hum Exp Toxicol | Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways. | 2021 | Details |
| A04288 | 33676874 | Surg Obes Relat Dis | The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis. | 2020 | Details |
| A04291 | 33675475 | Int Urol Nephrol | Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography. | 2021 | Details |
| A04296 | 33673073 | Int J Mol Sci | Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation. | 2021 | Details |
| A04298 | 33672864 | Life (Basel) | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. | 2021 | Details |
| A04302 | 33671926 | Int J Mol Sci | Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. | 2021 | Details |
| A04303 | 33671880 | Biomedicines | Immunomodulatory Role of Urolithin A on Metabolic Diseases. | 2021 | Details |
| A04304 | 33671850 | Nutrients | Omega-3 Polyunsaturated Fatty Acids Prevent Nonalcoholic Steatohepatitis (NASH) and Stimulate Adipogenesis. | 2021 | Details |
| A04307 | 33671547 | Int J Mol Sci | Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer. | 2021 | Details |
| A04311 | 33670347 | Nutrients | Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization. | 2021 | Details |
| A04312 | 33669443 | J Clin Med | Roles of Ceramides in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04313 | 33669288 | Int J Environ Res Public Health | Relationships between Socioeconomic Status, Handgrip Strength, and Non-Alcoholic Fatty Liver Disease in Middle-Aged Adults. | 2021 | Details |
| A04317 | 33667726 | Mol Metab | Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. | 2021 | Details |
| A04321 | 33665755 | Obes Surg | Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery. | 2021 | Details |
| A04325 | 33665203 | Front Nutr | The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories? | 2021 | Details |
| A04326 | 33665176 | Front Pediatr | Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity. | 2021 | Details |
| A04329 | 33664363 | Sci Rep | The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017. | 2021 | Details |
| A04332 | 33664007 | Arab J Gastroenterol | Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. | 2021 | Details |
| A04337 | 33659827 | Vavilovskii Zhurnal Genet Selektsii | Apoptosis in the liver of male db/db mice during the development of obesity and type 2 diabetes. | 2020 | Details |
| A04338 | 33658534 | Sci Rep | Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men. | 2021 | Details |
| A04342 | 33657584 | J Hypertens | Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population. | 2021 | Details |
| A04345 | 33656663 | Hepatol Int | Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease. | 2021 | Details |
| A04346 | 33655500 | Br J Pharmacol | Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis. | 2021 | Details |